MOSCOW (MRC) -- German industrial gas company Linde said second-quarter net profit was hit by adverse exchange-rate effects and competitive U.S. government healthcare tenders, but confirmed its outlook for the full year, as per The Wall Street Journal.
Second-quarter net profit was down 2.3% on the year to EUR334 million (USD448.9 million) from EUR342 million. This figure was slightly above analysts' expectations of EUR316 million.
Revenue declined slightly to EUR4.17 billion, in line with expectations. Linde said lower prices in the U.S. due to the introduction of competitive government tenders damped revenue and earnings.
The company maintained its 2014 guidance, despite currency headwinds that will continue to weigh on growth and profitability.
"We have proved our stability, although reported growth was again hampered by unfavorable exchange-rate effects," said Wolfgang Buchele, Linde's chief executive.
For the first half, revenue of the most important segment, industrial gases, declined 2.8% to nearly EUR6.83 billion. The engineering segment fared better with revenue rising 14% to EUR1.42 billion in the first half.
The company didn't offer any new information on its Russian business activities and the possible effects of sanctions. Linde's projects in the region include plans to build two hydrogen plants in Tartarstan, managing sites for the Russian petrochemical company SIBUR, and a joint venture in Samara for an ammonia plant.
The Linde Group is a world-leading gases and engineering company with around 62,000 employees in more than 100 countries worldwide.
MRC